Mice Model Market for Inbred Mice Segment to Grow Significantly during 2022–2028

According to our latest study on “Mice Model Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Service, Technology, Indication, End User, Application, and Mode,” the market is expected to grow from US$ 1,705.70 million in 2022 to US$ 2,340.90 million by 2028; it is estimated to grow at a CAGR of 5.4% from 2022 to 2028. The report highlights trends prevailing in the market and factors governing the market growth. Increased use of mice models in virology, infectious disease, and others; the rising demand for personalized medicine; and increased R&D activities are driving the mice model market. However, the stringent regulations and laws for the ethical use of animals in research are hindering the market growth.

Scientists have used animals to model human diseases for over a hundred years. Mice are particularly useful for this because they share many of the same biological traits as humans and have over 80 percent identical genetic components to humans. A mice model is a laboratory mouse used to study some aspect of human physiology or disease. Various model organisms are used in this regard, but mice are particularly useful because they share mammalian traits with humans and suffer from many of the same diseases. Many mice models have been created to target specific human diseases using selective breeding and genetic engineering. The use of mice models in disease research and research programs has contributed to significant medical breakthroughs. Mice are the model of choice, not only because they are strikingly similar to humans at the genomic level but also because the disease pathophysiology in mice is similar to humans. Mice are an inexpensive and efficient tool to speed up research and drug testing. These features provide researchers with a powerful tool for understanding the mechanisms of human disease and for testing novel drug therapies.

Get Sample PDF Report at :- https://www.theinsightpartners.com/sample/TIPRE00022453/?utm_source=issuu&utm_medium=10489

Leading companies operating in the market have undertaken various organic growth strategies in the mice model market. The mice model market is majorly comminuted by Charles River Laboratories; The Jackson Laboratory; Taconic Biosciences; TRANS GENIC INC.; GenOway S.A.; Envigo; Janvier Labs; Ozgene Pty Ltd.; Crown Bioscience Inc.; Harbour BioMed amongst others. The companies have been implementing various strategies that have helped their growth and, in turn, brought about several breakthroughs and transitions in the industry. The companies have utilized organic strategies such as launches, expansion, and product approvals. Moreover, the market players have also deployed several utilized inorganic strategies, including mergers & acquisitions, partnerships, and collaborations.

Mice models are essential tools to study the pathogenesis of infectious diseases and for the preclinical evaluation of vaccines and therapies against various human pathogens. The use of genetically defined inbred mouse strains, humanized mice, and gene knockout mice has enabled the research community to study the process of the way pathogens cause diseases, the role of specific host genes in controlling or promoting disease, and potential targets for prevention or identification of treatment for a variety of infectious agents. With the emergence of new infectious diseases, the animal model has become a vital tool for studying disease mechanisms and developing therapeutics. Mice with xenografted human immune systems have been used to study the pathogenesis of various infectious agents, including Plasmodium falciparum (malaria), Mycobacterium tuberculosis, dengue virus, and influenza virus. These models have been beneficial for studying HIV, including analyzing viral and host factors that promote viral replication, HIV interactions with the host’s immune response, and as platforms for testing therapeutic approaches to control or cure HIV infection. Mice models are an essential resource for studying the mechanisms underlying infectious disease pathogenesis and as platforms for testing potential vaccines and therapies. Mice models are necessary for learning about infections from many human pathogens. They are widely used for preclinical screening of vaccines/therapies because of their high reproducibility, low cost, and ease of experimental manipulation.

The report segments the mice model market as follows:

Based on type, the mice model market is categorized into inbred mice, outbred mice, genetically engineered mice, hybrid mice, surgically modified mice, and spontaneous mutant mice. Based on service, the market is segmented into breeding, cryopreservation, model-in licensing, genetic testing, quarantine, and others. Based on technology, the market is segmented into CRISPR, microinjection, embryonic stem cell injection, nuclear transfer, and others. Based on indication, the market is categorized into oncology studies, immunology & inflammation studies, endocrine metabolic studies, cardiovascular studies, central nervous system (CNS) studies, genetic studies, infectious disease studies, fibrosis, and other disease studies. Based on application, the market is segmented into preclinical drug development, biomarker analysis, and basic cancer research. Based on mode, the market is bifurcated into in-house and outsourced. Based on end user, the mice model market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, contract research organizations, and others. By geography, the market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South & Central America (Brazil, Argentina, and the Rest of SAM).

About The Insight Partners

The Insight Partners is a one-stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in industries such as healthcare, media, and telecommunication.

Our research model is very simple. We believe in client servicing and delivering the best quality to our customers. Through our research content, we are making sure that our customers get value for their money along with better quality data and analysis.

Our research content is majorly focused toward market trends in terms of market sizing, competitive landscaping, company analysis, regional or country analysis, etc. We provide a detailed break-up of segmentation in terms of geography, product and service, radioisotope types, application and end user, which helps our clients to gain a deeper analytical understanding of various research topics.

Contact Us

If you have any queries about this report or if you would like further information, please contact us:

North America: +1 646 491 9876

Asia Pacific: +91 20 6727 8686

Email: [email protected]